PFSA
NASDAQ HealthcareProfusa, Inc. - Common Stock
Medical Devices
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
๐ Market Data
| Price | $2.55 |
|---|---|
| Volume | 61,490,445 |
| Market Cap | 1.56M |
| Beta | 0.470 |
| RSI (14-Day) | 49.1 |
| 200-Day MA | $203.73 |
| 50-Day MA | $4.67 |
| 52-Week High | $3000.00 |
| 52-Week Low | $1.58 |
| Price / Book | -0.01 |
๐ฏ Investment Strategy Scores
PFSA scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (99/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Moon Shot (14/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find PFSA in your text
Paste any article, transcript, or post โ the tool will extract PFSA and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-24.